$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How long should I take bedaquiline? What medication schedule needs to be followed during treatment?
2026-02-01 22:25:32
Check Details
What is the dosage of dasatinib? How to adjust the dose according to the patient's condition?
2026-02-01 22:25:32
Check Details
Can Anamorelin be used long term? Safety and potential risks of long-term use
2026-02-01 22:25:32
Check Details
Can't I stop taking baricitinib once I start taking it? Long-term use requirements and discontinuation precautions
2026-02-01 22:25:32
Check Details
Is ruxolitinib cream effective in treating eczema? How it compares to other eczema treatments
2026-02-01 22:25:32
Check Details
Will upadatinib develop wildly after discontinuation? Is there a risk of recurrence or worsening of symptoms after discontinuing medication?
2026-02-01 22:25:32
Check Details
Pitobrutinib/pitobrutinib receives positive CHMP review for R/R CLL following use of covalent BTK inhibitor
2026-02-01 22:25:32
Check Details
Talazoparib/talazopanib combined with enzalutamide as first-line treatment for mCRPC improves OS
2026-02-01 22:25:32
Check Details
What are the side effects of Crizotinib/Xalkori? How to respond scientifically
2026-02-01 22:25:32
Check Details
Serpretinib/serpatinib demonstrates durable response in RET fusion-positive non-small cell lung cancer
2026-02-01 22:25:32
Check Details
We all know the efficacy and functions of ensidipine, and scientific medication is guaranteed!
2026-02-01 22:25:32
Check Details
Detailed explanation of the medical insurance reimbursement policy for avatrombopag/Sucoxin
2026-02-01 22:25:32
Check Details
1
2
...
1443
1444
1445
1446
1447
1448
1449
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
2
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
3
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
4
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
5
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
6
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
7
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
8
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
9
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
10
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
11
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
12
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis